Short answer
Tectonic Therapeutic, Inc. (TECX) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025.
Q3 2025 key financials · XBRL
- Net income
- −$19M
- −7.4% YoY · +4.7% QoQ
- EPS (diluted)
- −$1.02
- −117.6% YoY · +4.7% QoQ
Source: XBRL data from the Tectonic Therapeutic, Inc. (TECX) Q3 2025 10-Q on SEC EDGAR. USD.
Tectonic Therapeutic, Inc. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Forward-looking statements risk materially adverse differences from actual results
- Competitive, rapidly changing environment creates emerging business risks
- Management may not update forward-looking statements despite new information
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Tectonic Therapeutic, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.